| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjunction of a MEK inhibitor to Vemurafenib in the treatment of metastatic melanoma results in a 60% reduction of acute kidney injury
|
Teuma, Cécile
|
|
2017
|
79 |
5 |
p. 1043-1049
|
artikel
|
| 2 |
A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer
|
Wakelee, Heather A.
|
|
2017
|
79 |
5 |
p. 923-932
|
artikel
|
| 3 |
A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic cancer with arterial involvement
|
Nagakawa, Yuichi
|
|
2017
|
79 |
5 |
p. 951-957
|
artikel
|
| 4 |
A randomized, single-blind, single-dose study evaluating the pharmacokinetic equivalence of proposed biosimilar ABP 980 and trastuzumab in healthy male subjects
|
Hanes, Vladimir
|
|
2017
|
79 |
5 |
p. 881-888
|
artikel
|
| 5 |
Co-administration of proton pump inhibitors ameliorates nephrotoxicity in patients receiving chemotherapy with cisplatin and fluorouracil: a retrospective cohort study
|
Ikemura, Kenji
|
|
2017
|
79 |
5 |
p. 943-949
|
artikel
|
| 6 |
Comparative plasma and tissue distribution of Sun Pharma’s generic doxorubicin HCl liposome injection versus Caelyx® (doxorubicin HCl liposome injection) in syngeneic fibrosarcoma-bearing BALB/c mice and Sprague–Dawley rats
|
Burade, Vinod
|
|
2017
|
79 |
5 |
p. 899-913
|
artikel
|
| 7 |
Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer
|
Ohta, Hideki
|
|
2017
|
79 |
5 |
p. 1021-1029
|
artikel
|
| 8 |
Computed determination of the in vitro optimal chemocombinations of sphaeropsidin A with chemotherapeutic agents to combat melanomas
|
Ingels, Aude
|
|
2017
|
79 |
5 |
p. 971-983
|
artikel
|
| 9 |
Curcumin inhibits prostate cancer by targeting PGK1 in the FOXD3/miR-143 axis
|
Cao, Hongwen
|
|
2017
|
79 |
5 |
p. 985-994
|
artikel
|
| 10 |
Effective chemotherapy of heterogeneous and drug-resistant early colon cancers by intermittent dose schedules: a computer simulation study
|
Axelrod, David E.
|
|
2017
|
79 |
5 |
p. 889-898
|
artikel
|
| 11 |
Evaluation of the effect of the EGFR antibody-drug conjugate ABT-414 on QT interval prolongation in patients with advanced solid tumors likely to over-express EGFR
|
Munasinghe, Wijith P.
|
|
2017
|
79 |
5 |
p. 915-922
|
artikel
|
| 12 |
Genotoxicity kinetics in murine normoblasts as an approach for the in vivo action of difluorodeoxycytidine
|
Morales-Ramírez, Pedro
|
|
2017
|
79 |
5 |
p. 843-853
|
artikel
|
| 13 |
Increased ceramide production sensitizes breast cancer cell response to chemotherapy
|
Che, Jing
|
|
2017
|
79 |
5 |
p. 933-941
|
artikel
|
| 14 |
Low plasma concentration of gefitinib in patients with EGFR exon 21 L858R point mutations shortens progression-free survival
|
Okuda, Yuji
|
|
2017
|
79 |
5 |
p. 1013-1020
|
artikel
|
| 15 |
Luteolin induces apoptosis by ROS/ER stress and mitochondrial dysfunction in gliomablastoma
|
Wang, Qiang
|
|
2017
|
79 |
5 |
p. 1031-1041
|
artikel
|
| 16 |
One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival
|
Ito, Hiroki
|
|
2017
|
79 |
5 |
p. 855-861
|
artikel
|
| 17 |
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer
|
Rocca, Andrea
|
|
2017
|
79 |
5 |
p. 863-871
|
artikel
|
| 18 |
Potential drug–drug interactions with abiraterone in metastatic castration-resistant prostate cancer patients: a prevalence study in France
|
Bonnet, Clément
|
|
2017
|
79 |
5 |
p. 1051-1055
|
artikel
|
| 19 |
Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer
|
Jang, JoungSoon
|
|
2017
|
79 |
5 |
p. 873-880
|
artikel
|
| 20 |
The impact of a solitary kidney on tolerability to gemcitabine plus cisplatin chemotherapy in urothelial carcinoma patients: a retrospective study
|
Kondo, Masahiro
|
|
2017
|
79 |
5 |
p. 995-1001
|
artikel
|
| 21 |
Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivity
|
Tan, Qian
|
|
2017
|
79 |
5 |
p. 959-969
|
artikel
|
| 22 |
Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivity
|
Tan, Qian
|
|
|
79 |
5 |
p. 959-969
|
artikel
|
| 23 |
WBP2 modulates G1/S transition in ER+ breast cancer cells and is a direct target of miR-206
|
Ren, Yong-qiang
|
|
2017
|
79 |
5 |
p. 1003-1011
|
artikel
|
Tijdschrift beschrijving